MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 226 filers reported holding MYRIAD GENETICS INC in Q4 2016. The put-call ratio across all filers is 9.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $49,000 | -3.9% | 1,304 | -24.1% | 0.00% | 0.0% |
| Q1 2018 | $51,000 | +15.9% | 1,718 | +33.1% | 0.00% | 0.0% |
| Q4 2017 | $44,000 | +22.2% | 1,291 | +31.3% | 0.00% | 0.0% |
| Q3 2017 | $36,000 | +63.6% | 983 | +16.7% | 0.00% | 0.0% |
| Q2 2017 | $22,000 | +1000.0% | 842 | +573.6% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 125 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 125 | +7.8% | 0.00% | – |
| Q3 2016 | $2,000 | -50.0% | 116 | 0.0% | 0.00% | – |
| Q2 2016 | $4,000 | – | 116 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |